NASUS PHARMA LTD.
Nasus Pharma Ltd. is a health care company that develops powder-based Intranasal ( PBI ) specialized products to treat emergency patients.
NASUS PHARMA LTD.
Social Links:
Industry:
Health Care Medical Pharmaceutical
Founded:
2019-05-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.nasuspharma.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome ReCAPTCHA WordPress 6.0 Pound Sterling PayPal
Current Employees Featured
Official Site Inspections
http://www.nasuspharma.com Semrush global rank: 5.83 M Semrush visits lastest month: 1.42 K
- Host name: s-web33-il.upress.io
- IP address: 185.201.148.69
- Location: Israel
- Latitude: 31.5
- Longitude: 34.75
- Timezone: Asia/Jerusalem
More informations about "Nasus Pharma Ltd."
Home - Nasus Pharma
Nasus pharma develops powder-based Intranasal specialized product portfolio, to address acute medical conditions and public health threats. What we do? Based on our unique microsphere …See details»
About - Nasus Pharma
Nasus pharma brings the new frontier in Intranasal drug delivery. Late-Stage Specialty Pharma company, offers Powder-Based Intranasal (PBI) specialized product portfolio, to address acute …See details»
Company Leadership - Nasus Pharma
Nasus management consists of experienced pharma entrepreneurs. Board of directors Udi GilboaSee details»
Nasus Pharma Ltd. - Crunchbase Company Profile & Funding
Nasus Pharma Ltd. is a health care company that develops powder-based Intranasal ( PBI ) specialized products to treat emergency patients. View contacts for Nasus Pharma Ltd. to …See details»
Nasus Pharma - LinkedIn
Nasus pharma develops Powder-Based Intranasal (PBI) specialized product portfolio to address acute medical conditions & public health threats. Oren Elmaliah,CPA. Nasus Pharma | 515 followers on...See details»
Nasus Pharma - Powder-based Intra-nasal Products | Startup …
Oct 14, 2020 · Nasus Pharma is developing a number of intranasal powder products aimed at assisting patients in several acute emergency situations (such as opioid overdose and …See details»
Nasus Pharma Announces Positive Clinical Results of Recent Phase …
Dec 5, 2023 · FMXIN002 is an investigational intranasal epinephrine powder spray device that is noninvasive, needle-free, user-friendly and reliable and could provide timely effective rescue …See details»
Nasus Pharma - Overview, News & Similar companies - ZoomInfo
Aug 8, 2023 · View Nasus Pharma (www.nasuspharma.com) location in Tel Aviv, Israel , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Nasus Pharma Announces Data Demonstrating Efficacy of TaffiX ...
Jul 7, 2020 · Nasus Pharma, a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address acute medical …See details»
Nasus Pharma Announces Positive Results from a Pilot Clinical …
Jun 23, 2021 · Timely administration of epinephrine in cases of severe allergy and anaphylaxis is imperative in these life-threatening situations.See details»
Nasus Pharma Announces Positive Clinical Results of Recent Phase …
Dec 5, 2023 · Nasus Pharma Ltd a clinical-stage biopharmaceutical company focused on developing a needle-free, powder-based Intranasal (PBI) product portfolio to address acute …See details»
Nasus Pharma Announces Publication Of Its Positive Clinical …
Aug 8, 2023 · FMXIN002 is an investigational intranasal epinephrine powder spray device that is noninvasive, user-friendly and reliable and could provide timely effective rescue for severe …See details»
Nasus Pharma Announces Ground-Breaking Five Years Stability of …
Aug 6, 2024 · Nasus Pharma Ltd, a clinical-stage biopharmaceutical company focused on developing needle-free, powder-based Intranasal (PBI) product portfolio, to address acute …See details»
Nasus Pharma Announces Clinical Data Demonstrating Efficacy of …
Nov 24, 2021 · Based on its unique microsphere technology Nasus Pharma is developing a number of intranasal powder products aimed at assisting patients in several acute emergency …See details»
Nasus Pharma announces positive Results in Naloxone Pivotal Trial.
Apr 13, 2021 · Nasus Pharma Announces Positive Results in Pivotal Trial of FMXIN001 Naloxone Powder-Based Nasal Spray for the Treatment of opioid overdose. • Significantly higher rapid …See details»
Nasus Pharma Announces Positive Clinical Results of Recent
Dec 5, 2023 · Nasus Pharma Ltd a clinical-stage biopharmaceutical company focused on developing a needle-free, powder-based Intranasal (PBI) product portfolio to address acute …See details»
Nasus Pharma Announces Ground-Breaking Five Years Stability of …
TEL AVIV, Israel, Aug. 6, 2024 /PRNewswire/ -- Nasus Pharma Ltd, a clinical-stage biopharmaceutical company focused on developing needle-free, powder-based Intranasal …See details»
Technology - Nasus Pharma
NASAX-Powdered composition for intranasal delivery comprised of uniform spherical API’s and a carrier approved for inhalations. The active compound’s shape, size, and morphology in …See details»
Nasus Pharma Announces Positive Results from a Pilot Clinical …
Jun 23, 2021 · Results demonstrate rapid epinephrine absorption- for potentially quicker rescue of patients in anaphylactic shock.See details»
Nasus Pharma Announces Positive Results in Pivotal Trial of …
TEL AVIV, Israel, April 13, 2021 /PRNewswire/ -- Nasus Pharma Ltd, a clinical-stage biopharmaceutical company focused on developing needle-free, powder-based Intranasal …See details»